Psychological Well-Being of Adult Psoriasis Patients: A Narrative Review

Abstract

Psoriasis is a chronic systemic inflammatory condition, and psychiatric comorbidities are common in this condition. It is a non-communicable, autoimmune, and incurable disease. Psoriasis causes an adverse effect and is connected with various psychological symptoms like social isolation, guilt, and embarrassment of a patient. They decrease self-esteem because of depression, anxiety, stress, and substance abuse adults. The prevalence rate of adults is gradually increasing. This study uses various scales to evaluate the level of psoriasis. This study aims to evaluate the level of depression, anxiety, stress, and substance abuse among adult psoriasis patients and to identify the factors affecting psoriasis patients. A detailed search was carried out using essential databases such as PubMed, Google Scholar, and the World Health Organization (WHO) database to search for articles elucidating the same. In total articles, 36 out of 160 are selected. All studies found that psoriasis is at a positive level in that the level of depression and anxiety is moderate to severe, the level of stress is moderate, the level of alcohol abuse is higher, and the level of smoking consumption is ever-increasing. A severe skin condition that impacts the quality of life and psychological health. It has become a public health issue. All the selected articles assessed patients who were highly affected by depression, anxiety, stress, and abuse. They also assessed the various comorbidities related to psoriasis.

Involvement of Personality and Health Status in the Psychological Wellbeing of Subjects with Chronic Disease

“…Psychological wellbeing has become a global concern, particularly in the context of chronic pathologies [1][2][3]. Chronic illnesses negatively impact the physical, mental, and social aspects of an individual's life, posing a clear stress factor that threatens their wellbeing [4,5].…”

Relationship between body mass index and degree of adult psoriasis

“…Psoriasis is a chronic inflammatory disorder with increased numbers of Th1, Th17, and Th22 cells, leading to the synthesis of interferon-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-22 (1). Psoriasis is found in 1-3% of the global population (2), with prevalences in adults differing between countries but ranging from 0.51% to 11.43% (3). A cross-sectional study found a psoriasis prevalence of 2,5% in Indonesia (4).…”

Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas

“…Furthermore, depression, anxiety, stress, insomnia, and substance abuse have all been found to be higher in people with psoriasis compared with people without a skin condition. [1][2][3] Factors important to patients when discussing treatment options include overall symptom relief, rapid symptom relief, achieving and maintaining clear skin, effectiveness in 'high-impact' areas (such as the nails, scalp, palms, and soles), and the occurrence of side effects. 3 As psoriasis is a chronic disease, and loss of response is observed with some therapies over time, 4 studying long-term efficacy of new treatments is important.…”